TrialDiabetes, obesity & metabolism2020

Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.

Luigi Meneghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.